Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.
According to 2017 research in the journal Brain, Behavior, and Immunity, a single 20-minute brisk walk/jog on a treadmill ...
The use of IL-17 inhibitors in patients with psoriasis was associated with an increased risk for fungal infections when compared with other biologics.
The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.
PASADENA, CA, USA I November 04, 2024 I Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the ...
About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...
3d
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
A recent meta-analysis published in JAMA Neurology has revealed that tumor necrosis factor (TNF) inhibitors, widely used in treating autoimmune diseases, may increase the risk of ...
A heart attack can trigger a desire to get more sleep, allowing the heart to heal and reduce inflammation-;and this happens because the heart sends special signals to the brain, according to a new ...
A recent study from Mount Sinai reveals that after a heart attack, the heart signals the brain to increase sleep, helping the ...
INmune Bio Inc. (NASDAQ: INMB) (the“Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback